The influence of vitamin D receptor gene polymorphism on basal cell carcinoma development in the Polish population

Postepy Dermatologii i Alergologii

Volumn 28, Issue 3, 2011, Pages 165-169

  Lesiak, Aleksandra ^a   Wódz Naskiewicz, Karolina ^a   Pawliczak, Rafał ^a   Rogowski Tylman, Michał ^a   Sysa Jȩdrzejowska, Anna ^a   Sobjanek, Michał ^b   Włodarkiewicz, Adam ^b   Narbutt, Joanna ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Basal cell carcinoma; Cancerogenesis; VDR gene polymorphism

Indexed keywords

PROTEIN APAI; PROTEIN BSML; PROTEIN FOKI; PROTEIN TAQL; TUMOR PROTEIN; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER GROWTH; CANCER RISK; CONTROLLED STUDY; DNA POLYMORPHISM; EYE COLOR; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HAIR; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POLAND; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SKIN;

EID: 79960021539     PISSN: 1642395X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Housman TS, Feldman SR, Williford PM, et al. Skin cancer is among the most costly of all cancers to treat for the Medicare population. J Am Acad Dermatol 2003; 48: 425-9. (Pubitemid 36337080)
2. Lesiak A, Slowik-Rylska M, Rogowski-Tylman M, et al. Risk factors in Central Poland for the development of superficial and nodular basal cell carcinoma. Arch Med Sci 2010; 6: 270-5.
3. Bikle DD. Vitamin D receptor, UVR, and skin cancer: a potential protective mechanism. J Invest Dermatol 2008; 128: 2357-61.
4. Athar M, Tang X, Lee JL, et al. Hedgehog signalling in skin development and cancer. Exp Dermatol 2006; 15: 667-77. (Pubitemid 44145237)
5. Han J, Colditz GA, Hunter DJ. Polymorphisms in the MTHFR and VDR genes and skin cancer risk. Carcinogenesis 2007; 28: 390-7. (Pubitemid 46321855)
6. Wódz-Naskiewicz K, Narbutt J, Rogowski-Tylman M, et al. Association of methylenetetrahydrofolate reductase gene polymorphisms with basal cell carcinoma development. Post Dermatol Alergol 2011; 28: 1-5.
7. DeebKK, Trump DL, Johnson CS. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer 2007; 7: 684-700. (Pubitemid 47327412)
8. Zmuda JM, Cauley JA, Ferrell RE. Molecular epidemiology of vitamin D receptor gene variants. Epidemiol Rev 2000; 22: 203-17. (Pubitemid 32116092)
9. Ali MM, Vaidya V. Vitamin D and cancer. J Cancer Res Ther 2007; 3: 225-30.
10. Köstner K, Denzer N, Müller CS, et al. The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature. Anticancer Res 2009; 29: 3511-36.
11. Rukin NJ, Strange RC. What are the frequency, distribution, and functional effects of vitamin D receptor polymorphisms as related to cancer risk? Nutr Rev 2007; 65: S96-S101.
12. Slattery ML. Vitamin D receptor gene (VDR) associations with cancer. Nutr Rev 2007; 65: S102-S104.
13. Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 1988; 124: 869-71.
14. Gandini S, Raimondi S, Gnagnarella P, et al. Vitamin D and skin cancer: a meta-analysis. Eur J Cancer 2009; 45: 634-41.
15. Hutchinson PE, Osborne JE, Lear JT, et al. Vitamin D receptor polymorphisms are associated with altered prognosis in patients with malignant melanoma. Clin Cancer Res 2000; 6: 498-504. (Pubitemid 30111470)
16. Ma J, Stampfer MJ, Gann PH, et al. Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians. Cancer Epidemiol Biomarkers Prev 1998; 7: 385-90. (Pubitemid 28354126)
17. Carless MA, Kraska T, Lintell N, et al. Polymorphisms of the VDR gene are associated with presence of solar keratoses on the skin. Br J Dermatol 2008; 159: 804-10.
18. Dawson-Hughes B, Harris SS, Finneran S. Calcium absorption on high and low calcium intakes in relation to vitamin D receptor genotype. J Clin Endo Metab 1995; 80: 3657-61.
19. Santonocito C, Capizzi R, Concolino P, et al. Association between cutaneous melanoma, Breslow thickness and vitamin D receptor BsmI polymorphism. Br J Dermatol 2007; 156: 277-82. (Pubitemid 46095955)